Article Text

other Versions

PDF

Correction: Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Statistics from Altmetric.com

Hughes DA, Nicholls K, Shankar SP, et al. Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. J Med Genet 2017;54:288–96.

The correct trial protocol number for this study is: NCT01218659.

View Abstract

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Therapeutics
    Derralynn A Hughes Kathleen Nicholls Suma P Shankar Gere Sunder-Plassmann David Koeller Khan Nedd Gerard Vockley Takashi Hamazaki Robin Lachmann Toya Ohashi Iacopo Olivotto Norio Sakai Patrick Deegan David Dimmock François Eyskens Dominique P Germain Ozlem Goker-Alpan Eric Hachulla Ana Jovanovic Charles M Lourenco Ichiei Narita Mark Thomas William R Wilcox Daniel G Bichet Raphael Schiffmann Elizabeth Ludington Christopher Viereck John Kirk Julie Yu Franklin Johnson Pol Boudes Elfrida R Benjamin David J Lockhart Carrolee Barlow Nina Skuban Jeffrey P Castelli Jay Barth Ulla Feldt-Rasmussen